• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】30424

【品名】2-ethoxy-N-hydroxy-2-oxoethanimidoyl chloride

【CA登记号】14337-43-0

【 分 子 式 】C4H6ClNO3

【 分 子 量 】151.54928

【元素组成】C 31.7% H 3.99% Cl 23.39% N 9.24% O 31.67%

与该中间体有关的原料药合成路线共 6 条

合成路线1

该中间体在本合成路线中的序号:(II)

Condensation of ketoester (I) with ethyl chloro(hydroxymino)acetate (II) provided isoxazole (III), which was cyclized to isoxazolopyridazine (IV) using hydrazine. Alkylation of (II) with ethyl bromoacetate gave ester (V), which was finally hydrolyzed with NaOH to afford the title carboxylic acid.

1 Ciciani, G.; et al.; 5-Acyl-6-aryl-4-nitro-3(2H)pyridazinones and related 4-amino compounds: Synthesis and pharmacological evaluation. J Pharm Sci 1991, 80, 4, 341-348.
2 Barlocco, D.; Vianello, P.; Dal Piaz, V.; Constantino, L.; Giovannoni, M.P.; Gamberini, C.; Rastelli, G.; Isoxazolo-[3,4-d]-pyridazin-7-(6H)-one as a potential substrate for new aldose reductase inhibitors. J Med Chem 1999, 42, 11, 1894.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 30423 ethyl 3-(4-chlorophenyl)-3-oxopropanoate C11H11ClO3 详情 详情
(II) 30424 2-ethoxy-N-hydroxy-2-oxoethanimidoyl chloride 14337-43-0 C4H6ClNO3 详情 详情
(III) 30425 ethyl 4-(4-chlorobenzoyl)-5-methyl-3-isoxazolecarboxylate C14H12ClNO4 详情 详情
(IV) 30426 4-(4-chlorophenyl)-3-methylisoxazolo[3,4-d]pyridazin-7(6H)-one C12H8ClN3O2 详情 详情
(V) 30427 ethyl 2-[4-(4-chlorophenyl)-3-methyl-7-oxoisoxazolo[3,4-d]pyridazin-6(7H)-yl]acetate C16H14ClN3O4 详情 详情

合成路线2

该中间体在本合成路线中的序号:(V)

Reduction of N-(benzyloxycarbonyl)-4-hydroxyproline (I) with boranedimethylsulfide complex in THF provided the corresponding diol, which was selectively protected at the primary hydroxyl group as the tert-butyldimethylsilyl ether (II). Swern oxidation of the remaining secondary alcohol of (II) afforded ketone (III). This was converted to alkene (IV) by Wittig olefination with methylene triphenylphosphorane. The 1,3-dipolar cycloaddition of (IV) with the nitrile oxide generated from chlorooxime (V) and Et3N furnished spirocycle (VI) as a diastereomeric mixture. Deprotection of the silyl ether of (VI) by treatment with tetrabutylammonium fluoride, followed by Swern oxidation of the resulting alcohol provided aldehyde (VII). Reductive amination of (VII) with 2-aminopyridine (VIII) gave amine (IX), which was protected as the tert-butyl carbamate (X) using Boc2O.

1 Jadhav, P.K.; Smallheer, J.M. (DuPont Pharmaceuticals Co.); Spirocycle integrin inhibitors. EP 0888344; US 5760029; WO 9733887 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 36579 (2S,4S)-1-[(benzyloxy)carbonyl]-4-hydroxy-2-pyrrolidinecarboxylic acid 13504-85-3 C13H15NO5 详情 详情
(II) 36580 benzyl (2S,4S)-2-([[tert-butyl(dimethyl)silyl]oxy]methyl)-4-hydroxy-1-pyrrolidinecarboxylate C19H31NO4Si 详情 详情
(III) 36581 benzyl (2S)-2-([[tert-butyl(dimethyl)silyl]oxy]methyl)-4-oxo-1-pyrrolidinecarboxylate C19H29NO4Si 详情 详情
(IV) 36582 benzyl (2S)-2-([[tert-butyl(dimethyl)silyl]oxy]methyl)-4-methylene-1-pyrrolidinecarboxylate C20H31NO3Si 详情 详情
(V) 30424 2-ethoxy-N-hydroxy-2-oxoethanimidoyl chloride 14337-43-0 C4H6ClNO3 详情 详情
(VI) 36583 7-benzyl 3-ethyl 8-([[tert-butyl(dimethyl)silyl]oxy]methyl)-1-oxa-2,7-diazaspiro[4.4]non-2-ene-3,7-dicarboxylate C24H36N2O6Si 详情 详情
(VII) 36584 7-benzyl 3-ethyl 8-formyl-1-oxa-2,7-diazaspiro[4.4]non-2-ene-3,7-dicarboxylate C18H20N2O6 详情 详情
(VIII) 11305 2-Pyridinamine; 2-Pyridinylamine; 2-Aminopyridine 504-29-0 C5H6N2 详情 详情
(IX) 36585 7-benzyl 3-ethyl 8-[(2-pyridinylamino)methyl]-1-oxa-2,7-diazaspiro[4.4]non-2-ene-3,7-dicarboxylate C23H26N4O5 详情 详情
(X) 36586 7-benzyl 3-ethyl 8-[[(tert-butoxycarbonyl)(2-pyridinyl)amino]methyl]-1-oxa-2,7-diazaspiro[4.4]non-2-ene-3,7-dicarboxylate C28H34N4O7 详情 详情

合成路线3

该中间体在本合成路线中的序号:(II)

Cycloaddition of 5-hexen-1-ol (I) with (II) in presence of NaHCO3 yields isoxazoline (III). Alternatively (III) can be obtained by treatment of (I) with diethyl nitromalonate (A) in mesitylene. Isoxazoline (III) is then oxidized by means of Jones reagent to provide acid (IV) which is coupled in presence of BOP with the imidazole derivative (V) and hydrolyzed with LiOH affording derivative (VI). Acid (VI) is coupled with derivative (IX) (obtained by reaction of diaminopropionate (VII) with (VIII) in presence of DIEA) by means of BOP, and finally hydrolyzed to afford the desired product.

1 Withyak, J.; Pitts, W.J.; Smallheer, J.M.; et al.; Isoxazolines as potent antagonists of the integrin alphavbeta3. J Med Chem 2000, 43, 1, 27.
2 Voss, M.E.; Jadhav, P.K.; Smallheer, J.M.; Batt, D.G.; Pitts, W.J.; Wityak, J. (DuPont Pharmaceuticals Co.); Isoxazoline and isoxazole derivs. as integrin receptor antagonists. EP 0828737; JP 1999506436; US 5710159; WO 9637492 .
3 Jadhav, P.; Repta, A.J.; Pitts, W.J.; Hussain, M.A.; Batt, D.G. (DuPont Pharmaceuticals Co.); Heterocyclic integrin inhibitor prodrugs. WO 9843962 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 41159 diethyl 2-nitromalonate C7H11NO6 详情 详情
(I) 41152 5-hexen-1-ol 821-41-0 C6H12O 详情 详情
(II) 30424 2-ethoxy-N-hydroxy-2-oxoethanimidoyl chloride 14337-43-0 C4H6ClNO3 详情 详情
(III) 41153 ethyl 5-(4-hydroxybutyl)-4,5-dihydro-3-isoxazolecarboxylate C10H17NO4 详情 详情
(IV) 41154 4-[3-(ethoxycarbonyl)-4,5-dihydro-5-isoxazolyl]butyric acid C10H15NO5 详情 详情
(V) 41155 1H-imidazol-2-ylamine; 1H-imidazol-2-amine; 2-Aminoimidazole 7720-39-0 C3H5N3 详情 详情
(VI) 41156 5-[4-(1H-imidazol-2-ylamino)-4-oxobutyl]-4,5-dihydro-3-isoxazolecarboxylic acid C11H14N4O4 详情 详情
(VII) 41157 tert-butyl (2S)-2-amino-3-[(tert-butoxycarbonyl)amino]propanoate C12H24N2O4 详情 详情
(VIII) 41158 2,4,6-trimethylbenzenesulfonyl chloride 773-64-8 C9H11ClO2S 详情 详情
(IX) 36588 tert-butyl (2S)-3-amino-2-[(mesitylsulfonyl)amino]propanoate C16H26N2O4S 详情 详情

合成路线4

该中间体在本合成路线中的序号:(VIII)

Treatment of trans-4-hydroxy-L-proline (I) with p-nitrobenzyl chloroformate gave the N-protected 4-hydroxyproline (II), which was esterified to afford the N-protected methyl ester (II). Protection of the hydroxyl group of (III) with t-butyl-dimethylsilyl chloride in the presence of imidazole, followed by reduction of the resulting ester (IV) with lithium borohydride, provided the alcohol (V). This was oxidized using pyridine-sulfur trioxide complex to give the formylpyrrolidine (VI). The vinylpyrrolidine (VII) was obtained by Wittig reaction of aldehyde (VI) with methylene triphenylphosphorane. Dipolar cycloaddition of the nitrile oxide resulting from ethyl chlorooximidoacetate (VIII) and Et3N to vinylpyrrolidine (VII) gave iso-oxazolidine (IX) as a mixture of diastereoisomers. After desilylation of (IX) with tetrabutylammonium fluoride, the resulting alcohol (X) was converted into the diastereomeric mixture of mesylates (XI). Chromatographic separation of the required isomer, followed by reduction with LiBH4, yielded alcohol (XII).

1 Park, S.W.; Yoo, K.H.; Shin, K.J.; Kang, Y.K.; Hong, C.Y.; Seo, K.J.; Park, S.Y.; Lee, C.-S.; Kim, D.J.; Synthesis and antibacterial activity of new carbapenems containing isoxazole moiety. Bioorg Med Chem Lett 2000, 10, 2, 95.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14489 (2S,4R)-4-hydroxytetrahydro-1H-pyrrole-2-carboxylic acid; L-Hydroxyproline 51-35-4 C5H9NO3 详情 详情
(II) 22581 (2S,4R)-4-hydroxy-1-[[(4-nitrobenzyl)oxy]carbonyl]-2-pyrrolidinecarboxylic acid C13H14N2O7 详情 详情
(III) 44922 2-methyl 1-(4-nitrobenzyl) (2S,4R)-4-hydroxy-1,2-pyrrolidinedicarboxylate C14H16N2O7 详情 详情
(IV) 44923 2-methyl 1-(4-nitrobenzyl) (2S,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-1,2-pyrrolidinedicarboxylate C20H30N2O7Si 详情 详情
(V) 44924 4-nitrobenzyl (2S,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-(hydroxymethyl)-1-pyrrolidinecarboxylate C19H30N2O6Si 详情 详情
(VI) 44925 4-nitrobenzyl (2S,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-formyl-1-pyrrolidinecarboxylate C19H28N2O6Si 详情 详情
(VII) 44926 4-nitrobenzyl (2S,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-vinyl-1-pyrrolidinecarboxylate C20H30N2O5Si 详情 详情
(VIII) 30424 2-ethoxy-N-hydroxy-2-oxoethanimidoyl chloride 14337-43-0 C4H6ClNO3 详情 详情
(IX) 44927 ethyl (5R)-5-((2S,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-1-[[(4-nitrobenzyl)oxy]carbonyl]pyrrolidinyl)-4,5-dihydro-3-isoxazolecarboxylate C24H35N3O8Si 详情 详情
(X) 44928 ethyl (5R)-5-((2S,4R)-4-hydroxy-1-[[(4-nitrobenzyl)oxy]carbonyl]pyrrolidinyl)-4,5-dihydro-3-isoxazolecarboxylate C18H21N3O8 详情 详情
(XI) 44929 ethyl (5R)-5-((2S,4R)-4-[(methylsulfonyl)oxy]-1-[[(4-nitrobenzyl)oxy]carbonyl]pyrrolidinyl)-4,5-dihydro-3-isoxazolecarboxylate C19H23N3O10S 详情 详情
(XII) 44930 4-nitrobenzyl (2S,4R)-2-[(5R)-3-(hydroxymethyl)-4,5-dihydro-5-isoxazolyl]-4-[(methylsulfonyl)oxy]-1-pyrrolidinecarboxylate C17H21N3O9S 详情 详情

合成路线5

该中间体在本合成路线中的序号:(VI)

Reduction of protected hydroxyproline (I) by means of borane dimethylsulfide complex (BH3-Me2S) in THF affords protected hydroxy prolinol (II), which is then treated with tert-butyldimethylsilyl chloride and Et3N in CH2Cl2 to provide hydroxypyrrolidine derivative (III). Swern oxidation of (III) by means of oxalyl chloride in DMSO/CH2Cl2 yields pyrrolidinone (IV), which is then converted into methylenepyrrolidine (V) by reaction with methyltriphenylphosphonium bromide and KOtBu in ether. Treatment of (V) with ethyl chlorooximidoacetate (VI) and Et3N in CH2Cl2 gives spiro compound (VII), which is then subjected to saponification by treatment with LiOH in MeOH to afford carboxylic acid (VIII). Coupling of (VIII) with amine (IX) by means of BOPCl and N-methylmorpholine (NMM) in DMF furnishes amide (X), which is then converted into aldehyde (XI) by first TBDMS removal by treatment with tetrabutylammonium fluoride (TBAF) in THF and oxidation with Dess-Martin periodinane. Reductive amination of aldehyde (XI) with amine (XII) by means of Na(AcO)3BH in benzene/1,2-dichloroethane followed by treatment with Boc2O provides compound (XIII), whose Cbz is selectively removed by hydrogenation over Pd/Ba2SO4 to give secondary amine (XIV). Finally, acylation of (XIV) with chloroformate (XV) followed by Boc removal by means of TFA allows to obtain the desired product.

1 Jadhav, P.K.; Smallheer, J.M. (DuPont Pharmaceuticals Co.); Spirocycle integrin inhibitors. EP 0888344; US 5760029; WO 9733887 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 36579 (2S,4S)-1-[(benzyloxy)carbonyl]-4-hydroxy-2-pyrrolidinecarboxylic acid 13504-85-3 C13H15NO5 详情 详情
(II) 48432 benzyl (2S,4S)-4-hydroxy-2-(hydroxymethyl)-1-pyrrolidinecarboxylate C13H17NO4 详情 详情
(III) 36580 benzyl (2S,4S)-2-([[tert-butyl(dimethyl)silyl]oxy]methyl)-4-hydroxy-1-pyrrolidinecarboxylate C19H31NO4Si 详情 详情
(IV) 36581 benzyl (2S)-2-([[tert-butyl(dimethyl)silyl]oxy]methyl)-4-oxo-1-pyrrolidinecarboxylate C19H29NO4Si 详情 详情
(V) 36582 benzyl (2S)-2-([[tert-butyl(dimethyl)silyl]oxy]methyl)-4-methylene-1-pyrrolidinecarboxylate C20H31NO3Si 详情 详情
(VI) 30424 2-ethoxy-N-hydroxy-2-oxoethanimidoyl chloride 14337-43-0 C4H6ClNO3 详情 详情
(VII) 48433 7-benzyl 3-ethyl (5R,8S)-8-([[tert-butyl(dimethyl)silyl]oxy]methyl)-1-oxa-2,7-diazaspiro[4.4]non-2-ene-3,7-dicarboxylate C24H36N2O6Si 详情 详情
(VIII) 48434 (5R,8S)-7-[(benzyloxy)carbonyl]-8-([[tert-butyl(dimethyl)silyl]oxy]methyl)-1-oxa-2,7-diazaspiro[4.4]non-2-ene-3-carboxylic acid C22H32N2O6Si 详情 详情
(IX) 36588 tert-butyl (2S)-3-amino-2-[(mesitylsulfonyl)amino]propanoate C16H26N2O4S 详情 详情
(X) 48435 benzyl (5R,8S)-3-[([(2S)-3-(tert-butoxy)-2-[(mesitylsulfonyl)amino]-3-oxopropyl]amino)carbonyl]-8-([[tert-butyl(dimethyl)silyl]oxy]methyl)-1-oxa-2,7-diazaspiro[4.4]non-2-ene-7-carboxylate C38H56N4O9SSi 详情 详情
(XI) 48436 benzyl (5R,8S)-3-[([(2S)-3-(tert-butoxy)-2-[(mesitylsulfonyl)amino]-3-oxopropyl]amino)carbonyl]-8-formyl-1-oxa-2,7-diazaspiro[4.4]non-2-ene-7-carboxylate C32H40N4O9S 详情 详情
(XII) 48437 2-Aminobenzimidazole; 2-Amino-1H-benzimidazol; 1H-Benzimidazol-2-amine; 2-Benzimidazolamine 934-32-7 C7H7N3 详情 详情
(XIII) 48438 benzyl (5R,8S)-8-[[1H-benzimidazol-2-yl(tert-butoxycarbonyl)amino]methyl]-3-[([(2S)-3-(tert-butoxy)-2-[(mesitylsulfonyl)amino]-3-oxopropyl]amino)carbonyl]-1-oxa-2,7-diazaspiro[4.4]non-2-ene-7-carboxylate C44H55N7O10S 详情 详情
(XIV) 48439 tert-butyl (2S)-3-[[((5R,8S)-8-[[1H-benzimidazol-2-yl(tert-butoxycarbonyl)amino]methyl]-1-oxa-2,7-diazaspiro[4.4]non-2-en-3-yl)carbonyl]amino]-2-[(mesitylsulfonyl)amino]propanoate C36H49N7O8S 详情 详情
(XV) 48440 1-[(chlorocarbonyl)oxy]butane C5H9ClO2 详情 详情

合成路线6

该中间体在本合成路线中的序号:(III)

The mono-Boc protected amino cyclopentenecarboxylate (I) is converted to the di-Boc derivative (II) by means of di-tert-butyl dicarbonate and DMAP. Dipolar cycloaddition of the nitrile oxide generated from ethyl 2-chloro-2-(hydroxyimino)acetate (III) to cyclopentene (II) gives the cis-fused cyclopentaisoxazole (IV) as a diastereomeric mixture. After cleavage of the acidic Boc groups, the desired isomer (V) can be isolated by column chromatography. Finally, alkaline hydrolysis of the ethyl ester functions of (V) affords the target dicarboxylic acid.

1 Conti, P.; De Amici, M.; Di Ventimiglia, S.J.; Stensbol, T.B.; Madsen, U.; Brauner-Osborne, H.; Russo, E.; De Sarro, G.; Bruno, G.; De Micheli, C.; Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids. J Med Chem 2003, 46, 14, 3102.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 64706 ethyl 1-[(tert-butoxycarbonyl)amino]-3-cyclopentene-1-carboxylate C13H21NO4 详情 详情
(II) 64707 ethyl 1-[bis(tert-butoxycarbonyl)amino]-3-cyclopentene-1-carboxylate C18H29NO6 详情 详情
(III) 30424 2-ethoxy-N-hydroxy-2-oxoethanimidoyl chloride 14337-43-0 C4H6ClNO3 详情 详情
(IV) 64708 diethyl (3aS,6aS)-5-[bis(tert-butoxycarbonyl)amino]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-3,5-dicarboxylate C22H34N2O9 详情 详情
(V) 64709 diethyl (3aS,5R,6aS)-5-amino-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-3,5-dicarboxylate C12H18N2O5 详情 详情
Extended Information